(BPC stands for Body Protective Compound.) Its available as an injection or oral pill, and its touted as a regenerative peptide that promotes tissue repair, improves exercise recovery, and prevents injury
The groundbreaking Galderma clinical research confirms what weve observed in our practice: the combination of biostimulators with fillers produces superior results to either treatment alone
Fracture Risk Data from GLP1 Trials Several cardiovascular outcomes trials (CVOTs) have collected fracture data as secondary outcomes: Trials involving semaglutide and dulaglutide generally report fracture rates similar to placebo A few studies suggest a potential increase in non-vertebral fractures, though findings are inconsistent and often not statistically significant One important confounder is weight loss, which itself can lead to bone loss
Wang RQ, Deng ZM, Chen GT, Dai FF, Xia LB
note that liver function tests are adjunctive and do not reliably reflect disease severity on their own Note: Measures such as HOMA-IR (a research tool for estimating insulin resistance) are not routinely used in UK clinical practice and are more relevant in a research or trial context